Globes -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) states in a notice to the US Securities and Exchange Commission (SEC) that if Cephalon Inc. (Nasdaq: CEPH) cancels its acquisition by Teva, it will pay a fine of 4% of the $6.8 billion deal - or $275 million.
According to the joint presentation by the two companies following the acquisition announcement on Monday, Teva will still have more than $1 billion in cash after closing the deal. It said that its balance sheet has “sufficient liquidity for future strategic opportunities.”
